Editorial Article
The Industry Optimises to Avoid the Word Nano
Five substances in seventeen years
The European Union has had a dedicated nanomaterial regime for cosmetic products since Regulation (EC) No 1223/2009 took effect, and the record of what it has cleared is short enough to list in full.
Four UV filters have been authorised as nanomaterials: methylene bis-benzotriazolyl tetramethylbutylphenol, titanium dioxide, zinc oxide and tris-biphenyl triazine. Carbon black has been allowed as a nanomaterial colourant. That is the entire authorised set, and it is the number that matters when anyone forecasts a nanoencapsulation market.
Those five sit in the strictest corner of the regime. Colourants, preservatives and UV filters must be authorised by the Commission before use, and authorisation follows a risk assessment by the Scientific Committee on Consumer Safety. For every other nanomaterial there is a different route: a specific notification in the cosmetics products notification portal six months before the product is placed on the market, under Article 16(3), provided the material is not otherwise restricted.
The definition does the sorting, and it sorts on chemistry, not on size
In cosmetics, a nanomaterial means an insoluble or biopersistent, intentionally manufactured material with one or more external dimensions, or an internal structure, on a scale from 1 to 100 nanometres.
Two words in that sentence carry all the commercial weight: insoluble and biopersistent. A soft, soluble, swellable or biodegradable carrier can be well under 100 nanometres and fall outside the definition. A solid, inert particle can be outside the size threshold and still be regulated on chemistry grounds if it behaves as a nanomaterial.
Which means the population of particles that a formulation chemist would call encapsulated is not the population of particles the regulation counts. That gap is where the industry lives, and it is not an accident. It is the rational response to two costs that attach to the definition: a six-month notification per product before launch, and a labelling obligation that requires the word “nano” in brackets after the ingredient name in the ingredient list.
The label is the expensive part
Regulatory costs are usually thought of as compliance costs – dossiers, tests, consultants. For a consumer product, the more powerful cost is the one printed on the pack, because it changes what the product can claim.
In a category where “free from” is the dominant marketing language, a bracketed “nano” next to an ingredient name is a liability. The engineering response is entirely predictable, and it is visible across the industry: shift to carriers above the size threshold, use soluble or swellable systems that fall outside the definition, replace an inorganic encapsulation with a coacervate or a spray-dried matrix, and describe the result as microencapsulation.
So the technology spreads, but the vocabulary does not. The encapsulation that reaches the market is disproportionately the encapsulation that does not have to be notified, and the growth shows up in microcapsules, coacervates, liposomes and spray-dried systems measured in hundreds of nanometres rather than in tens. The “nano” label has done what all labelling regimes do: it has created a market for not being in the category.
The queue is the ceiling, not the science
The second constraint is throughput. Authorisation of a nanomaterial UV filter requires an SCCS opinion, which requires a toxicological dossier, and the Commission has completed four in the lifetime of the regime. Four is not a criticism of the applicants. It is the observed rate of a process that has a scientific committee, a public consultation and a comitology step in it.
Any forecast of a nanoencapsulation market that assumes laboratory capability converts into commercial volume is assuming a regulatory queue moves several times faster than it has ever moved. That assumption is invisible in the published figures, because those figures are built from technology capability and patent counts rather than from authorisation dates.
There is a third data point that says the same thing from the Commission’s side. Article 16(10a) requires the Commission to publish a catalogue of all nanomaterials used in cosmetic products placed on the market. The agency’s own page still lists version 2 of that catalogue, dated 31 December 2018, alongside version 1 from 2016. An inventory that has not been revised in the better part of a decade is an inventory of a slow-moving category, not a fast one.
Where the technology actually earns
Strip out the regulatory framing and nanoencapsulation is a cost per kilogram of active that has to be justified by what it protects. That is why it clusters where the active is expensive, unstable or hazardous: a pharmaceutical payload where bioavailability decides whether the drug works, an omega-3 or a vitamin where oxidation decides shelf life, a pheromone where volatilisation decides whether a pest control product lasts a season, a probiotic where viability decides the claim.
The mechanical trade is always the same. Encapsulation adds a process step, a material cost and a release specification, and it removes a failure mode. In a commodity application the failure mode is cheaper to accept. In a high-value active the failure mode is the product.
Which means the growth of encapsulation is a function of the value of what is being encapsulated, not of the sophistication of the carrier. That is a more useful forecasting rule than any technology adoption curve, and it is why the strongest demand pull is in pharmaceuticals and in high-value food and agricultural actives, where the regulatory regime that governs the carrier is often the pharmaceutical one rather than the cosmetic one.
Why the published market sizes are unusable
Pheonix does not publish a nanoencapsulation market size, and the reason is structural rather than cautious.
The perimeter of the market is a legal definition that industry actively engineers around. Count the things called nano and you count a population that formulators are trying to leave. Count the things that encapsulate at 200 to 500 nanometres and you count a population the regulation does not see. Add the fact that encapsulation capacity is often a step inside a customer’s own process rather than a purchased product, and a single number becomes a statement about which of those perimeters the analyst happened to choose.
What is decision-useful is narrower and harder: the authorisation calendar for the materials that must be authorised, the notification burden for the ones that must be notified, and the value of the active being protected. Those three determine where the technology earns its cost, and none of them is a market size.
Frequently Asked Questions
How are nanomaterials regulated in EU cosmetic products?
Responsible persons must state in their product notification whether the product contains nanomaterials. Nanomaterials that are not colourants, preservatives or UV filters and are not otherwise restricted require a separate notification six months before the product is placed on the market under Article 16(3).
How many nanomaterials have been authorised for use in cosmetics?
Four UV filters - MBBT, titanium dioxide, zinc oxide and tris-biphenyl triazine - and one colourant, carbon black, according to the European Commission. Those are the substances that had to be authorised before use.
Does nanoencapsulation always require a nanomaterial notification?
No. The cosmetic definition covers insoluble or biopersistent intentionally manufactured materials with dimensions or internal structure from 1 to 100 nanometres. Soluble, swellable or biodegradable carriers fall outside it, which is why much commercial encapsulation work migrates to carriers above the threshold.
What is the market size of nanoencapsulation?
Pheonix does not publish one. The market's perimeter is a legal definition that formulators engineer around, and encapsulation capacity is frequently a step inside a customer's own process rather than a purchased product, so a single figure reflects the analyst's chosen perimeter rather than a commercial reality.
